Patients with NAFLD exhibit more advanced fibrosis in liver biopsy than patients with other chronic liver diseases
Zeitschrift für Gastroenterologie · 01.01.2023 · 61 (01) · 29-36
DOI: 10.1055/a-1960-4006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.01.2023. Verfasst von Lydia Rohr und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Ruhr University Bochum, Bochum, Germany. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Introduction
Despite extremely high and seemingly rising prevalence of non-alcoholic fatty liver disease (NAFLD), awareness for this health condition is still low. In the present study we analyzed, if this is reflected in clinical routine for advanced diagnostic measures.
Methods
Retrospective data of 93 patients with histologically determined fibrosis stage and confirmed etiology was analyzed. Patients were grouped according to chronic liver disease alone (n=40), concomitant chronic liver disease and NAFLD (n=29), or NAFLD alone (n=24). Fibrosis stage and presence of cirrhosis were main outcome measures.
Results
Patients with NAFLD were significantly older and had significantly higher body mass index and CAP-values than patients with chronic liver disease. Significantly higher fibrosis stages were observed in patients with NAFLD than in those with chronic liver disease alone (p=0.003). Presence of cirrhosis was significantly higher in patients with NAFLD than in patients with chronic liver disease (p=0.01). This was not associated with a significantly different age distribution over fibrosis stages between chronic liver disease and NAFLD. Undergoing liver biopsy 10 years earlier could have possibly prevented progression to cirrhosis in up to 7 patients with NAFLD. This could have potentially saved 35,000 € yearly health care resources.
Conclusion
These findings suggest that the time course for development of liver fibrosis and cirrhosis is not fundamentally different between patients with NAFLD or with other chronic liver diseases. Higher rates of cirrhosis observed in patients with NAFLD could potentially be ameliorated by earlier diagnostic work-up and improved monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medicine, Ruhr University Bochum, Bochum, Germany.
- Department of Gastroenterology, Hepatology, and Infectious Diseases, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
- Pathologie, Ruhruniversität, Bochum, Germany.
- Medizinische Klinik, Universitätsklinikum Knappschaftskrankenhaus Bochum GmbH, Bochum, Germany.
ORCID-Profile: Jan-Peter Sowa
Zitieren
APA
Rohr, L., Lemmer, P., Henning, M., Tannapfel, A., Baars, T., Manka, P., Canbay, A., & Sowa, J. P. (2023). Patients with NAFLD exhibit more advanced fibrosis in liver biopsy than patients with other chronic liver diseases. Zeitschrift für Gastroenterologie, 61(01), 29-36. https://doi.org/10.1055/a-1960-4006
Vancouver
Rohr L, Lemmer P, Henning M, Tannapfel A, Baars T, Manka P, et al. Patients with NAFLD exhibit more advanced fibrosis in liver biopsy than patients with other chronic liver diseases. Zeitschrift für Gastroenterologie. 2023;61(01):29-36. doi:10.1055/a-1960-4006
BibTeX
@article{Rohr2023,
author = {Rohr, Lydia and Lemmer, Peter and Henning, Marie and Tannapfel, Andrea and Baars, Theodor and Manka, Paul and Canbay, Ali and Sowa, Jan-Peter},
title = {Patients with NAFLD exhibit more advanced fibrosis in liver biopsy than patients with other chronic liver diseases},
journal = {Zeitschrift für Gastroenterologie},
year = {2023},
volume = {61},
number = {01},
pages = {29--36},
doi = {10.1055/a-1960-4006}
}
EUVIMED